A Study to Investigate Subcutaneous Isatuximab in Combination With Carfilzomib and Dexamethasone in Adult Participants With Relapsed and/or Refractory Multiple Myeloma
Clinical trial NCT05704049 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05704049
- Sponsor
- Sanofi
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-05
- Primary completion
- 2025-12-22
- Enrollment
- 118
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.